Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3…
Trial met primary endpoint, with KarXT demonstrating a statistically significant 9.6-point reduction in PANSS Total Score compared to placebo at Week 5 (p<0.0001) Trial also met key…